SCHEMBL6868508

SCHEMBL6868508

CN(C)c1nc(N[C@H]2CC[C@@H](NC(=S)Nc3ccc(Cl)cc3)CC2)nc2c1CCCC2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.50
ADRA2A P08913 3/20 0.46
MCHR1 Q99705 3/20 0.46
HRH1 P35367 2/20 0.46
HTR2B P41595 2/20 0.46
BCHE P06276 1/20 0.43
ACHE P22303 1/20 0.43
SMN1; SMN2 Q16637 6/20 0.41
LMNA P02545 4/20 0.41
CYP2C19 P33261 2/20 0.41
ALDH1A1 P00352 2/20 0.41
CYP2D6 P10635 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ADRA1A P35348 1/20 0.41
RAB9A P51151 4/20 0.40
NPC1 O15118 2/20 0.40
POLB P06746 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
MAPT P10636 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6868513 1.00 NPSR1 (0.50) NPSR1ADRA2AMCHR1HRH1HTR2B
SCHEMBL6878792 0.91 SMN1; SMN2 (0.43) NPSR1ADRA2AMCHR1HRH1HTR2B
SCHEMBL6878795 0.91 SMN1; SMN2 (0.43) NPSR1ADRA2AMCHR1HRH1HTR2B
SCHEMBL6878845 0.91 SMN1; SMN2 (0.52) ADRA2AMCHR1HRH1HTR2BSMN1; SMN2
SCHEMBL6878840 0.91 SMN1; SMN2 (0.52) ADRA2AMCHR1HRH1HTR2BSMN1; SMN2
SCHEMBL6878669 0.90 SMN1; SMN2 (0.54) NPSR1ADRA2AMCHR1HRH1HTR2B
SCHEMBL6878673 0.90 SMN1; SMN2 (0.54) NPSR1ADRA2AMCHR1HRH1HTR2B
SCHEMBL6875295 0.90 MCHR1 (0.40) NPSR1ADRA2AMCHR1HRH1HTR2B
SCHEMBL6875288 0.90 MCHR1 (0.40) NPSR1ADRA2AMCHR1HRH1HTR2B
SCHEMBL6456275 0.90 SMN1; SMN2 (0.41) NPSR1ADRA2AMCHR1HRH1HTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1464335-A2 Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist Taisho Pharmaceutical Co. Ltd. (JP) 2004-10-06 EP disclosed